SKELID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Skelid, and when can generic versions of Skelid launch?
Skelid is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in SKELID is tiludronate disodium. There is one drug master file entry for this compound. Additional details are available on the tiludronate disodium profile page.
Summary for SKELID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 1 |
Patent Applications: | 1,264 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SKELID at DailyMed |
Recent Clinical Trials for SKELID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assistance Publique - Hôpitaux de Paris | Phase 3 |
US Patents and Regulatory Information for SKELID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | SKELID | tiludronate disodium | TABLET;ORAL | 020707-001 | Mar 7, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SKELID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | SKELID | tiludronate disodium | TABLET;ORAL | 020707-001 | Mar 7, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | SKELID | tiludronate disodium | TABLET;ORAL | 020707-001 | Mar 7, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SKELID
See the table below for patents covering SKELID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S5942395 | ANTIINFLAMMATORY PRODUCT DERIVED FROM METHYLENE-DIPHOSPHONIC ACID | ⤷ Try a Trial |
Australia | 3258889 | ⤷ Try a Trial | |
Austria | 30235 | ⤷ Try a Trial | |
Morocco | 19858 | ⤷ Try a Trial | |
Finland | 75830 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SKELID
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0100718 | 96C0006 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TILUDRONATE DISODIQUE EXPRIME EN ACIDE TILUDRONIQUE; NAT. REGISTRATION NO/DATE: 201 IS 106 F 3 19950907; FIRST REGISTRATION: LI 53014 19950220 |
0100718 | SPC/GB96/027 | United Kingdom | ⤷ Try a Trial | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |